257 related articles for article (PubMed ID: 25420513)
1. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.
Kumamoto M; Toyonaga A; Inoue H; Miyakoda K; Morita Y; Emori K; Sakamoto Y; Oho K; Sata M
J Gastroenterol Hepatol; 2010 Jun; 25(6):1129-35. PubMed ID: 20594229
[TBL] [Abstract][Full Text] [Related]
3. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.
Miyamoto Y; Oho K; Kumamoto M; Toyonaga A; Sata M
J Gastroenterol Hepatol; 2003 Aug; 18(8):934-42. PubMed ID: 12859723
[TBL] [Abstract][Full Text] [Related]
4. Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient.
Uehara H; Akahoshi T; Tomikawa M; Kinjo N; Hashimoto N; Nagao Y; Kamori M; Maehara Y
J Gastroenterol Hepatol; 2012 Jan; 27(1):137-41. PubMed ID: 21722180
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
Kato T; Uematsu T; Nishigaki Y; Sugihara J; Tomita E; Moriwaki H
Intern Med; 2001 Aug; 40(8):688-91. PubMed ID: 11518103
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience.
Akahoshi T; Hashizume M; Tomikawa M; Kawanaka H; Yamaguchi S; Konishi K; Kinjo N; Maehara Y
J Gastroenterol Hepatol; 2008 Nov; 23(11):1702-9. PubMed ID: 18713295
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.
Takashimizu S; Watanabe N; Kojima S; Kagawa T; Mine T; Myojin K; Koizumi J
Tokai J Exp Clin Med; 2007 Jul; 32(2):70-4. PubMed ID: 21319062
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for portosystemic shunts.
Waguri N; Hayashi M; Yokoo T; Sato R; Arao Y; Setsu T; Sato M; Kohisa J; Hama I; Ohsugi K; Aiba T; Yoneyama O; Furukawa K; Sugimura K; Igarashi K; Suda T
J Vasc Interv Radiol; 2012 May; 23(5):650-7. PubMed ID: 22459878
[TBL] [Abstract][Full Text] [Related]
9. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Maeda M; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
J Gastroenterol Hepatol; 2019 Jan; 34(1):215-223. PubMed ID: 30070412
[TBL] [Abstract][Full Text] [Related]
10. Control of solitary gastric fundal varices and portosystemic encephalopathy accompanying liver cirrhosis by balloon-occluded retrograde transvenous obliteration (B-RTO): a case report.
Ohmoto K; Miyake I; Tsuduki M; Ohno S; Yamamoto S
Hepatogastroenterology; 1999; 46(26):1249-52. PubMed ID: 10370701
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.
Fukuda T; Hirota S; Sugimura K
J Vasc Interv Radiol; 2001 Mar; 12(3):327-36. PubMed ID: 11287510
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
[TBL] [Abstract][Full Text] [Related]
13. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
[TBL] [Abstract][Full Text] [Related]
14. Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration.
Kasuga A; Mizumoto H; Matsutani S; Kobayashi A; Endo T; Ando T; Yukisawa S; Maruyama H; Yokosuka O
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):898-903. PubMed ID: 20461439
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
16. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients.
Ninoi T; Nishida N; Kaminou T; Sakai Y; Kitayama T; Hamuro M; Yamada R; Nakamura K; Arakawa T; Inoue Y
AJR Am J Roentgenol; 2005 Apr; 184(4):1340-6. PubMed ID: 15788621
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of balloon-occluded retrograde transvenous obliteration for gastric varices concurrent with hepatocellular carcinoma.
Matsuoka S; Tamura A; Ishii T; Miyazawa S; Mizutani T; Ito K; Kamimura S; Matsumoto N; Nakamura H; Nirei K; Matsumura H; Yamagami H; Moriyama M; Takayama T
Hepatogastroenterology; 2014; 61(136):2301-4. PubMed ID: 25699370
[TBL] [Abstract][Full Text] [Related]
18. Balloon-occluded retrograde transvenous obliteration of varices: focusing on the portal hemodynamics and the recent techniques.
Hirota S; Kobayashi K; Kako Y; Takaki H; Yamakado K
Hepatol Int; 2018 Feb; 12(Suppl 1):102-111. PubMed ID: 28875380
[TBL] [Abstract][Full Text] [Related]
19. Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy.
Lee EW; Lee AE; Saab S; Kee ST
Dig Dis Sci; 2020 Sep; 65(9):2483-2491. PubMed ID: 32002756
[TBL] [Abstract][Full Text] [Related]
20. [Balloon-occluded retrograde transvenous obliteration (B-RTO) for portal hypertension].
Hirota S; Fukuda T; Matsumoto S; Sugimoto K; Isaki K; Yoshikawa T; Akasaka Y; Sugimura K
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jun; 60(7):361-7. PubMed ID: 10921294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
